Featured Articles
-
Accelerating Bulk Harvest Testing Using A CHO Animal Origin Free Virus Panel
10/19/2023
Here, we describe the design and performance of a degenerate PCR-based approach to broad virus screening that can be used in testing bulk harvest material derived from CHO cells.
-
Ensuring Biomanufacturing Resilience For Biologics And Vaccines
10/19/2023
We highlight strategies for ensuring the reliable delivery of health technologies with a focus on vaccines, mAbs, and new modalities manufactured by biotechnology companies and institutes.
-
Improving The Characterization Of Gene Therapy Products
10/19/2023
The analysis of over 10 variant callers and other bioinformatics tools for viral variant detection are discussed to better understand how the outcomes can improve gene therapy product characterization.
-
Accelerated Monoclonal Antibody Development
9/26/2023
Hear from some of the experts who were instrumental in developing the Accelerated mAb development program and work with biotech companies on a daily basis to accelerate their production timelines.
-
Development Of A Novel Cell Culture Medium For AAV Production
9/26/2023
Explore the medium development process of a novel cell culture medium for AAV production with multiple HEK293 lineages, which was performed with three different HEK293 cell lines to maximize AAV titers.
-
From Myth To Mastery: Unveiling The Secrets Of Virus Bank Manufacturing
9/12/2023
It is crucial to start off your product development right. Here, you will learn how to best approach virus bank production. Review best practices, how to overcome common obstacles, and more.
-
Kick It Off Right: A Successful Cell Bank Manufacture
9/12/2023
Learn about best practices for cell bank manufacturing, how to get the most out of your cell bank, the future of closed processing in line with Annex 1, and more.
-
Why Choosing A Client-Centric CTDMO Is Critical In Biomanufacturing
9/11/2023
Outsourcing to a CTDMO is a promising solution for companies lacking the technical expertise and in-house capacity to address biomanufacturing challenges. Learn why selecting the right CTDMO partner is vital for project success.
-
Industry-Leading Lentiviral Titers Through Optimized Production Technology
8/28/2023
See how VirusExpress' technology was optimized to provide industry-leading lentiviral titer and a streamlined approach to accelerate development timelines and de-risk manufacturing.
-
Eliminating USP <88> In Vivo Animal Bioreactivity Testing For Polymer Characterization
8/25/2023
There has been growing awareness about the environmental and ethical implications of plastics used in bioprocessing. The time for a shift to well-studied, proven in vitro cytotoxicity testing is now.